Citi downgraded Corteva (CTVA) to Neutral from Buy with a price target of $67, down from $83, following the company’s plan to spin-off its Seeds business. JPMorgan upgraded Corteva this morning. Citi sees a challenging 2026 setup for the shares as it does not believe the separation will unlock additional shareholder value. The company’s brings more uncertainty amid adds an uncertain macro backdrop, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva upgraded to Overweight from Neutral at JPMorgan
- Corteva’s Strategic Split: Unlocking Value and Growth Potential with a Buy Rating
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Corteva to separate into two publicly traded companies
- Oppenheimer maintains bullish stance on Corteva following split reports